Coronavirus: Chinese test kits approved for use across Europe, United States
- Despite the war of words between lawmakers and diplomats, Chinese and American companies are working together in the fight against Covid-19
- Chinese Genome sequencing company BGI Group says its RT-PCR product became commercially available in the United States on Wednesday
It had also been granted a CE certification mark to sell the product within the European Economic Area, the company said.
According to its website, BGI has performed more than 500,000 tests in China and is now distributing its kits to over 50 countries and regions around the world.
The announcement of the kit’s availability in America came after the US Food and Drug Administration (FDA) decided to expedite clinical testing for SARS-CoV-2 – the official name for the novel coronavirus – by allowing companies to start selling tests before they have been reviewed by federal authorities or granted official emergency clearance.
As of Sunday, the United States had reported more than 26,000 infections and 340 deaths, according to figures provided by Johns Hopkins University.